Westminster Health Forum

The future of biosimilars in the UK - innovation, regulation and increasing uptake

Morning, Thursday, 18th October 2018

Central London

THIS EVENT IS CPD CERTIFIED



This seminar will consider the next steps in the development of biosimilars and their potential to generate cost-savings throughout the NHS.


Planned sessions will look at what lessons can be applied from the Cancer Vanguard in the adoption of biosimilars - as well as the wider impact of the Life Sciences Industrial Strategy in bringing new biological medicines to the market, and encouraging investment in biosimilar exports and manufacturing.


Further sessions will assess what more might be done to support the uptake of biosimilars in the NHS - including priorities for increasing engagement with clinicians, developing local commissioning frameworks and promoting patient choice.



Guest of Honour

Dr Christian Schneider

Director, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency

Guest of Honour

Dr Christian Schneider

Director, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency

Chair

Daniel Zeichner MP

Speaker

Julie Wood

Chief Executive, NHS Clinical Commissioners